A detailed history of Palogic Value Management, L.P. transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Palogic Value Management, L.P. holds 650,000 shares of HCAT stock, worth $2.52 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
650,000
Previous 676,900 3.97%
Holding current value
$2.52 Million
Previous $4.59 Billion 35.82%
% of portfolio
1.3%
Previous 1.98%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 16, 2025

SELL
$3.97 - $7.42 $106,793 - $199,598
-26,900 Reduced 3.97%
650,000 $2.94 Billion
Q1 2025

May 15, 2025

BUY
$3.97 - $7.42 $1.42 Million - $2.65 Million
356,900 Added 111.53%
676,900 $4.59 Billion
Q4 2024

Feb 11, 2025

BUY
$6.9 - $9.02 $2.21 Million - $2.89 Million
320,000 New
320,000 $2.26 Billion

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $212M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Palogic Value Management, L.P. Portfolio

Follow Palogic Value Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palogic Value Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Palogic Value Management, L.P. with notifications on news.